Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ9V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,938
Award facts
- Contract value 100% obligated
- $50,937.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,937.55 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packages) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is to be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., is a critical federal vendor specializing in delivering prescription medications, medical devices, and healthcare commodities to military treatment facilities and other government healthcare systems. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to meet federal procurement requirements through competitive bidding across diverse therapeutic domains. This delivery order for Gemtesa, a medication used in treating overactive bladder, exemplifies the type of specialty pharmaceutical products the company routinely supplies to support military medical operations and federal healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FMJ9V?
SPE2DR26FMJ9V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FMJ9V worth?
The government has obligated $50,938 on SPE2DR26FMJ9V.
Is contract SPE2DR26FMJ9V an order under another contract?
Yes. SPE2DR26FMJ9V is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ9V competed?
The extent of competition for SPE2DR26FMJ9V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award